Study to Assess the Effect of AZD9291 on the Blood Levels of Simvastatin in Patients With EGFRm+ NSCLC

NCT02197234 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

PROCEDURE: Pharmacokinetic sampling - AZD9291
DRUG: Simvastatin
DRUG: AZD9291 tablet dosing
PROCEDURE: Pharmacokinetic sampling - simvastatin
PROCEDURE: Pharmacokinetic sampling - AZ5140 and AZ7550

Sponsor

AstraZeneca